Methyltestosterone
Metandren, Oreton Methyl (methyltestosterone) is a small molecule pharmaceutical. Methyltestosterone was first approved as Metandren on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, erectile dysfunction, and hypogonadism in the USA. The pharmaceutical is active against androgen receptor.
| Trade Name | Metandren, Oreton Methyl |
|---|---|
| Common Name | Methyltestosterone |
| Indication | breast neoplasms, delayed puberty, erectile dysfunction, hypogonadism |
| Drug Class | Steroids (androgens, anabolics) |
